BioPearl™ Microspheres Loaded With Doxorubicin: Prospective, Single Arm, Multi-centre Post-market Follow-up Study.

NCT04231929 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study cancelled by Sponsor decision

Conditions

Hepatocellular Carcinoma

Interventions

DEVICE: Chemoembolization

Sponsor

Terumo Europe N.V.